• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Mineralys Therapeutics, Inc. - Common Stock (NQ: MLYS )

    13.50 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Mineralys Therapeutics, Inc. - Common Stock

    MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm!
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    MLYS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Mineralys Therapeutics, Inc. and Encourages Investors to Contact the Firm!
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    MLYS Investors Have Opportunity to Join Mineralys Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    Mineralys Therapeutics Earnings Preview
    Via Benzinga
    Where Mineralys Therapeutics Stands With Analysts
    Via Benzinga
    MLYS Stock Earnings: Mineralys Therapeutics Misses EPS for Q2 2024
    MLYS stock results show that Mineralys Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    MLYS Stock Earnings: Mineralys Therapeutics Misses EPS for Q1 2024
    MLYS stock results show that Mineralys Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    MLYS Stock Earnings: Mineralys Therapeutics Beats EPS for Q4 2023
    MLYS stock results show that Mineralys Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace
    Arm Holdings Posts Upbeat Results, Joins Hershey, CyberArk Software, Wynn Resorts And Other Big Stocks Moving Higher On Thursday
    U.S. stocks traded mixed, with the Dow Jones gaining around 20 points on Thursday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Where Mineralys Therapeutics Stands With Analysts
    Via Benzinga
    Earnings Scheduled For March 21, 2024
    Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session following downbeat results. 
    Via Benzinga
    Praxis Bioresearch Expands its Board of Directors with Appointment of Adam Levy
    From Praxis Bioresearch, Inc.
    Via GlobeNewswire
    Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results. 
    Via Benzinga
    $5M Bet On TreeHouse Foods? Check Out These 3 Stocks Insiders Are Buying
    Although U.S. stocks closed higher on Friday, there were a few notable insider trades. 
    Via Benzinga
    The Acute Hospital Care Market Is Worth Over $3 Trillion, And Windtree Therapeutics Brings A First-In-Class Drug To An Active Segment Of This Market
    The global acute hospital care market was worth $3.2 trillion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.62% from 2023 to 2030. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
      On Tuesday, 74 companies achieved new lows for the year. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
    Via Benzinga
    Earnings Scheduled For March 15, 2023
    Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. 
    Via Benzinga
    Around $11M Bet On Insight Enterprises? Check Out These 4 Stocks Insiders Are Buying
    Although US stocks closed lower on Thursday, there were a few notable insider trades. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
      During Tuesday, 40 stocks hit new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
      On Monday, 42 companies hit new 52-week lows. 
    Via Benzinga
    There's a Lot to Love About Mineralys' Valentine's Day IPO
    MLYS added 20% more shares to IPO funding, which goes live on 2/14. The bump secured liquidity to stabilize development, improving market cap to $683 million 
    Via MarketBeat
    Topics Initial Public Offering
    Exposures Securities Market
    Opening Day: Hesai Scores Biggest U.S. Debut By Chinese Company Since Didi
    Shares of Hesai, a developer of sensor technologies used in self-driving cars, jumped as much as 29% in its first trading day, making the listing the largest by a Chinese issuer in the U.S. since Didi... 
    Via Talk Markets
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.